Prevention and Treatment of Intestinal Failure-Associated Liver Disease in Children

Lorenzo Norsa1, Emanuele Nicastro2, Angelo Di Giorgio3

  • 1Pediatric Gastroenterology Hepatology and Nutrition, Ospedale Papa Giovanni XXIII, 24127 Bergamo, Italy. lnorsa@asst-pg23.it.

Nutrients
|June 9, 2018
PubMed

Insights

Intestinal failure-associated liver disease (IFALD) in children is a serious complication of long-term parenteral nutrition. Early management and prevention strategies are crucial for managing IFALD and avoiding liver transplantation.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Intestinal Rehabilitation

Background:

  • Intestinal failure-associated liver disease (IFALD) poses a significant threat to children requiring long-term parenteral nutrition.
  • Progressive IFALD can impede intestinal rehabilitation and necessitate combined liver-intestinal transplantation.
  • Dedicated intestinal failure centers have successfully reduced IFALD incidence.

Purpose of the Study:

  • To review the etiology and risk factors of IFALD.
  • To highlight key prevention strategies, including nutritional management and infection control.
  • To discuss current and emerging therapeutic interventions for IFALD.

Main Methods:

  • Literature review of IFALD etiology, risk factors, prevention, and treatment.
  • Analysis of evidence from dedicated intestinal failure centers.
  • Synthesis of current medical and surgical treatment strategies.

Main Results:

  • Early and proactive management can prevent IFALD progression to end-stage liver disease.
  • Nutritional optimization and strict control of catheter-related infections are primary preventive measures.
  • Timely intervention can lead to the resolution of IFALD.

Conclusions:

  • IFALD is a preventable complication with appropriate management.
  • Multidisciplinary care in intestinal failure centers is vital for IFALD prevention and treatment.
  • Further research into advanced therapeutic strategies is ongoing.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.0K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
968
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
709
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
633
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
87.6K